4XI9, 5C1D
5934
19651
ENSG00000103479
ENSMUSG00000031666
Q08999
Q64700
NM_005611NM_001323608NM_001323609NM_001323610NM_001323611
NM_001282000NM_001282001NM_011250
NP_001310537NP_001310538NP_001310539NP_001310540NP_005602
NP_001268929NP_001268930NP_035380
Retinoblastoma-like protein 2 is a protein that in humans is encoded by the RBL2 gene.[5][6] RBL2 is one of three retinoblastoma proteins encoded in the human genome (along with Rb and RBL1).
Retinoblastoma-like protein 2 has been shown to interact with:
Mutations in RBL2 have been linked to a severe neurodevelopmental disorder characterised by morphological and behavioural abnormalities. Symptoms include intellectual disability, developmental delay, microcephaly, dysmorphic features, gait abnormalities, and seizures.[18][19][20]
The genetic basis of RBL2-linked disease is caused by bi-allelic loss-of-function mutations (including nonsense mutations, frameshifts, splicing mutations, and deletions.[18]
RBL2-linked disease is a rare genetic disorder with only 35 patients identified worldwide (2025).[18]
This article incorporates text from the United States National Library of Medicine, which is in the public domain.